PMID- 22472558 OWN - NLM STAT- MEDLINE DCOM- 20130501 LR - 20220129 IS - 1555-3892 (Electronic) IS - 0963-6897 (Print) IS - 0963-6897 (Linking) VI - 21 IP - 6 DP - 2012 TI - Isolation of myogenic stem cells from cultures of cryopreserved human skeletal muscle. PG - 1087-93 LID - 10.3727/096368912X636876 [doi] AB - We demonstrate that subpopulations of adult human skeletal muscle-derived stem cells, myogenic endothelial cells (MECs), and perivascular stem cells (PSCs) can be simultaneously purified by fluorescence-activated cell sorting (FACS) from cryopreserved human primary skeletal muscle cell cultures (cryo-hPSMCs). For FACS isolation, we utilized a combination of cell lineage markers: the myogenic cell marker CD56, the endothelial cell marker UEA-1 receptor (UEA-1R), and the perivascular cell marker CD146. MECs expressing all three cell lineage markers (CD56(+)UEA-1R(+)CD146(+)/CD45(-)) and PSCs expressing only CD146 (CD146(+)/CD45(-)CD56(-)UEA-1R(-)) were isolated by FACS. To evaluate their myogenic capacities, the sorted cells, with and without expansion in culture, were transplanted into the cardiotoxin-injured skeletal muscles of immunodeficient mice. The purified MECs exhibited the highest regenerative capacity in the injured mouse muscles among all cell fractions tested, while PSCs remained superior to myoblasts and the unpurified primary skeletal muscle cells. Our findings show that both MECs and PSCs retain their high myogenic potentials after in vitro expansion, cryopreservation, and FACS sorting. The current study demonstrates that myogenic stem cells are prospectively isolatable from long-term cryopreserved primary skeletal muscle cell cultures. We emphasize the potential application of this new approach to extract therapeutic stem cells from human muscle cells cryogenically banked for clinical purposes. FAU - Zheng, Bo AU - Zheng B AD - Stem Cell Research Center, Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA. FAU - Chen, Chien-Wen AU - Chen CW FAU - Li, Guangheng AU - Li G FAU - Thompson, Seth D AU - Thompson SD FAU - Poddar, Minakshi AU - Poddar M FAU - Peault, Bruno AU - Peault B FAU - Huard, Johnny AU - Huard J LA - eng GR - R21 HL083057-01A2/HL/NHLBI NIH HHS/United States GR - G1000816/MRC_/Medical Research Council/United Kingdom GR - R01DE013420-09/DE/NIDCR NIH HHS/United States GR - R21 HL083057/HL/NHLBI NIH HHS/United States GR - R01 DE013420/DE/NIDCR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20120402 PL - United States TA - Cell Transplant JT - Cell transplantation JID - 9208854 RN - 0 (CD146 Antigen) RN - 0 (CD56 Antigen) RN - 0 (Transcription Factors) RN - EC 2.3.2.23 (UBE2V1 protein, human) RN - EC 2.3.2.23 (Ubiquitin-Conjugating Enzymes) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Animals MH - CD146 Antigen/metabolism MH - CD56 Antigen/metabolism MH - Cell Differentiation MH - Cell Lineage MH - Cells, Cultured MH - Child MH - Child, Preschool MH - Cryopreservation MH - Endothelial Cells/cytology MH - Female MH - Flow Cytometry MH - Humans MH - Male MH - Mice MH - Mice, SCID MH - Middle Aged MH - Muscle, Skeletal/*cytology MH - Regeneration/physiology MH - Stem Cell Transplantation MH - Stem Cells/*cytology/metabolism MH - Transcription Factors/metabolism MH - Ubiquitin-Conjugating Enzymes/metabolism MH - Young Adult PMC - PMC4356195 MID - NIHMS669167 EDAT- 2012/04/05 06:00 MHDA- 2013/05/02 06:00 PMCR- 2015/03/11 CRDT- 2012/04/05 06:00 PHST- 2012/04/05 06:00 [entrez] PHST- 2012/04/05 06:00 [pubmed] PHST- 2013/05/02 06:00 [medline] PHST- 2015/03/11 00:00 [pmc-release] AID - ct0204zheng [pii] AID - 10.3727/096368912X636876 [doi] PST - ppublish SO - Cell Transplant. 2012;21(6):1087-93. doi: 10.3727/096368912X636876. Epub 2012 Apr 2.